Biopticon Corporation
10 News & Press Releases found

Biopticon Corporation news

Visit us at our booth #407. We are announcing the launch of our next generation 3D scanner for subcutaneous tumors on mice and rats. We simply named it TumorImager 2TM. We will demonstrate both hands-free and hand-held versions during the convention from June 15th through 17th.

Mar. 28, 2022

This venue was postponed until further notice.

We are going to present our TMS for the 10th time during the 2020 AACR in San Diego (April 26th- April 29th). 

Dec. 27, 2019

Visit our booth #231 at 18th Annual WPC in Boston, June 17-20, 2019  to view our company’s latest products and advancements.

Apr. 29, 2019

We are going to present our TMS for the 9th time during the 2019 AACR in Atlanta (March 29th– April 3rd).  Please visit 

Mar. 8, 2019

Our second European presence is at World Preclinical Congress meeting in Lisbon, Portugal. Visit our booth #14 between November 27-30.

Oct. 5, 2018

This is our 8th year at the show. We would be happy to show you our new imager, TumorImager-2TM. Please visit us at our booth #1921.

Mar. 26, 2018

This year, we are going to present TMS for the first time in Europe. Visit our booth #117 at ESMO (European Society for Medical Oncology) 2018 in Munich Germany, in October 19-23.

Mar. 26, 2018

Visit us at our booth #942

Washington DC, April 1-5, 2017

Biopticon will be in Washington DC for the annual 2017 AACR convention. Visit us at our booth Biopticon Corporation Booth.

Mar. 16, 2017

Biopticon Corporation Announces the release of the new version of their innovative TumorManagerTM Program for managing pre-clinical oncology study data

Innovative instrument and software create revolutionary system to improve data, work-flow and results from in vivo cancer models

Princeton, NJ

Biopticon today released the latest version of their 

Jan. 5, 2012

Biopticon Corporation reaches milestone in market adoption of their innovative Tumor Management System for preclinical oncology studies.

Innovative instrument and software create revolutionary system to improve data, work-flow and results from in vivo cancer models

Princeton, NJ Biopticon today announced that it had met its first milestone for customer adoption of the revolutionary 

Sep. 30, 2011